Previous close | 2.4000 |
Open | 2.4000 |
Bid | 2.1000 |
Ask | 2.5900 |
Strike | 250.00 |
Expiry date | 2025-01-17 |
Day's range | 2.4000 - 2.4000 |
Contract range | N/A |
Volume | |
Open interest | 859 |
Novavax gets green light from FDA, awaits CDC recommendation for booster COVID doses.
The Serum Institute of India has received a recommendation from WHO for malaria doses using a Novavax adjuvant.
(Bloomberg) -- Novavax Inc.’s updated version of its Covid-19 shot gained US regulators’ authorization for emergency use amid a rocky rollout of competitors’ offerings.Most Read from BloombergKey Taiwan Tech Firms Helping Huawei With China Chip PlantsWhy a US Recession Is Still Likely — and Coming SoonWall Street Fear Gauge Ratchets Up After Jobs Data: Markets WrapKevin McCarthy Ousted as US House Speaker by Republican DissidentsAirbnb Is Fundamentally Broken, Its CEO Says. He Plans to Fix It.Th